Liver abscess following radioembolization with yttrium-90 microspheres
Radioembolization with yttrium-90 microspheres is an accepted and useful intervention model with minimal invasion in both primary and secondary liver malignancies. Radioembolization may lead to some complications. Liver abscess is a rare complication that can occur several weeks after radioembolization treatment of liver tumor with yttrium-90 ...
Korkmaz, Mehmet +6 more
core +7 more sources
Radioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases [PDF]
PURPOSEWe aimed to evaluate the effectiveness and safety of radioembolization with yttrium-90 (90Y) microspheres in cases with unresectable neuroendocrine tumor liver metastases (NETLMs).METHODSThirty patients (mean age, 55 years) underwent resin-based ...
Ahmet Peker +4 more
doaj +2 more sources
Yttrium-90 Resin Microspheres and their Use in the Treatment of Intrahepatic Cholangiocarcinoma
Intrahepatic cholangiocarcinoma (ICC) is a severe and rapidly progressive hepatic tumor. Surgery is often impracticable due to locally advanced presentation. On the other hand, chemotherapy has demonstrated only limited effectiveness. For these reasons, liver-directed therapies have been successfully applied for treating ICC.
Filippi L. +3 more
core +6 more sources
Side Effects of Yttrium-90 Radioembolization [PDF]
Limited therapeutic options are available for hepatic malignancies. Image guided targeted therapies have established their role in management of primary and secondary hepatic malignancies.
Ahsun eRiaz, Rafia eAwais, Riad eSalem
doaj +2 more sources
Selective intraarterial radionuclide therapy with yttrium-90 (Y-90) microspheres for hepatic neuroendocrine metastases: Initial experience at a single center [PDF]
Background/Aim. Selective intraarterial radionuclide therapy (SIRT) with Yttrium-90 (Y-90) microspheres is also known as radioembolization and delivers high doses of radiation to hepatic tumors with minimum healthy liver exposure.
Arslan Nuri +8 more
doaj +2 more sources
Internal dosimetry for radioembolization therapy with Yttrium-90 microspheres. [PDF]
AbstractThe absorbed doses in the liver and adjacent viscera in Yttrium‐90 radioembolization therapy for metastatic liver lesions are not well‐documented. We sought for a clinically practical way to determine the dosimetry of this advent treatment. Six different female XCAT BMIs and seven different male XCAT BMIs were generated.
Fallahpoor M +3 more
europepmc +8 more sources
Armeen Mahvash,1 Ravi Murthy,1 Bruno C Odisio,1 Kanwal Pratap Raghav,2 Lauren Girard,2 Sheree Cheung,1 Van Nguyen,3 Joe Ensor,4 Sameer Gadani,5 Khaled M Elsayes,6 Reham Abdel-Wahab,1,7 Manal Hassan,1 Ahmed S Shalaby,1 James C Yao,1 Michael J Wallace,1 ...
Mahvash A +15 more
doaj +1 more source
Radioembolization of Yttrium-90 Microspheres for Hepatic Malignancy [PDF]
The liver represents a frequent site for primary and secondary neoplasia. Cytoreductive techniques positively influence the outcome of disease progression in these patients. Transhepatic arterial radioembolotherapy utilizing yttrium-90 microspheres represents a recently available in situ therapy that has shown encouraging results in the treatment of ...
Ravi, Murthy +3 more
openaire +2 more sources
YTTRIUM-90 MICROSPHERE RADIOEMBOLIZATION FOR UNRESECTABLE CHOLANGIOCARCINOMA
The term radioembolization defines those procedures in which intra-arterially injected radioactive microspheres are used for internal radiation purposes. The aim of this procedure is to selectively target radiation to liver tumors and to limit the dose to the normal liver parenchyma.
Cristina Mosconi +3 more
core +3 more sources
Yttrium-90 microspheres: a review of its emerging clinical indications. [PDF]
<b><i>Background: </i></b>Many patients with liver malignancies are not candidates for resection, and systemic therapies are often not effective. Radioembolization (RE) is an alternative treatment for this group of patients. The safety and efficacy of RE with yttrium 90 (Y90) in patients with hepatocellular carcinoma (HCC) or ...
Khajornjiraphan N, Thu NA, Chow PK.
europepmc +3 more sources

